Trial Profile
The Effectiveness and Safety of Neoadjuvant Pegylated Liposomal Doxorubicin and Docetaxel in Breast Cancer.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 15 Feb 2018
Price :
$35
*
At a glance
- Drugs Doxorubicin liposomal (Primary) ; Paclitaxel
- Indications Breast cancer
- Focus Therapeutic Use
- 21 Jul 2017 New trial record